Ovid Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $144.0M
Liabilities Breakdown FY2023
Total Liabilities: $56.2M
Asset Breakdown
Total Assets: $144.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $27.0M | 18.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $769.0K | 0.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $200.0K | 0.1% |
| Other Assets | $116.0M | 80.6% |
Liabilities Breakdown
Total Liabilities: $56.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.7M | 6.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $52.5M | 93.4% |